Immunohistochemistry images of colon cancer tissues and study of the TCGA (The Cancer Genome Atlas) database both implied the reduction of SLC35C1 and elevation of β‐catenin in all stages of colon cancer. This evidence concerns the gene SLC35C1 and colonic neoplasm.